94 results on '"Seeger, Werner"'
Search Results
2. Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes.
- Author
-
Bischoff, Florian C., Werner, Astrid, John, David, Boeckel, Jes-Niels, Melissari, Maria-Theodora, Grote, Phillip, Glaser, Simone F., Demolli, Shemsi, Uchida, Shizuka, Michalik, Katharina M., Meder, Benjamin, Katus, Hugo A., Haas, Jan, Wei Chen, Pullamsetti, Soni S., Seeger, Werner, Zeiher, Andreas M., Dimmeler, Stefanie, and Zehendner, Christoph M.
- Published
- 2017
- Full Text
- View/download PDF
3. The Max Planck Institute for Heart and Lung Research Curiosity-Driven Basic Research to Fight Cardio-Pulmonary Diseases.
- Author
-
Braun, Thomas, Offermanns, Stefan, Stainier, Didier Y. R., and Seeger, Werner
- Published
- 2017
- Full Text
- View/download PDF
4. Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling.
- Author
-
Weisel, Friederike Christine, Kloepping, Christina, Pichl, Alexandra, Sydykov, Akylbek, Kojonazarov, Baktybek, Wilhelm, Jochen, Roth, Markus, Ridge, Karen Marie, Igarashi, Kazuei, Nishimura, Kazuhiro, Maison, Wolfgang, Wackendorff, Claudia, Klepetko, Walter, Jaksch, Peter, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Seeger, Werner, Schermuly, Ralph Theo, Weissmann, Norbert, and Kwapiszewska, Grazyna
- Published
- 2014
- Full Text
- View/download PDF
5. Arterial hypertension in a murine model of sleep apnea: role of NADPH oxidase 2.
- Author
-
Schulz, Richard, Murzabekova, Gulsina, Egemnazarov, Bakytbek, Kraut, Simone, Eisele, Hans-Joachim, Dumitrascu, Rio, Heitmann, Jörg, Seimetz, Michael, Witzenrath, Martin, Ghofrani, Hossein A, Schermuly, Ralph T, Grimminger, Friedrich, Seeger, Werner, and Weissmann, Norbert
- Published
- 2014
- Full Text
- View/download PDF
6. MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts.
- Author
-
Wang, Daren, Zhang, Hui, Li, Min, Frid, Maria G., Flockton, Amanda R., McKeon, B. Alexandre, Yeager, Michael E., Fini, Mehdi A., Morrell, Nicholas W., Pullamsetti, Soni S., Velegala, Sivareddy, Seeger, Werner, McKinsey, Timothy A., Sucharov, Carmen C., and Stenmark, Kurt R.
- Published
- 2014
- Full Text
- View/download PDF
7. PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension.
- Author
-
Kwapiszewska, Grazyna, Markart, Philipp, Dahal, Bhola Kumar, Kojonazarov, Baktybek, Marsh, Leigh Matthew, Schermuly, Ralph Theo, Taube, Christian, Meinhardt, Andreas, Ghofrani, Hossein Ardeschir, Steinhoff, Martin, Seeger, Werner, Preissner, Klaus Theo, Olschewski, Andrea, Weissmann, Norbert, and Wygrecka, Malgorzata
- Published
- 2012
- Full Text
- View/download PDF
8. Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung*.
- Author
-
Ruppert, Clemens, Kuchenbuch, Tim, Boensch, Marc, Schmidt, Sebastian, Mathes, Uwe, Hillebrand, Vera, Henneke, Ingrid, Markart, Philipp, Reiss, Irwin, Schermuly, Ralph T., Seeger, Werner, and Günther, Andreas
- Published
- 2010
- Full Text
- View/download PDF
9. INDUCTION OF LYMPHOCYTE APOPTOSIS IN A MURINE MODEL OF ACUTE LUNG INJURY-MODULATION BY LIPID EMULSIONS.
- Author
-
Bi, Ming Hua, Ott, Juliane, Fischer, Tobias, Hecker, Matthias, Dietrich, Hartmut, Schaefer, Martina Barbara, Markart, Philip, Wang, Bao En, Seeger, Werner, and Mayer, Konstantin
- Published
- 2010
- Full Text
- View/download PDF
10. Staphylococcus aureus α-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts.
- Author
-
Grandel, Ulrich, Bennemann, Ulrich, Buerke, Michael, Hattar, Katja, Seeger, Werner, Grimminger, Friedrich, and Sibelius, Ulf
- Published
- 2009
- Full Text
- View/download PDF
11. The lectin-like domain of tumor necrosis factor-α improves alveolar fluid balance in injured isolated rabbit lungs.
- Author
-
Vadász, István, Schermuly, Ralph T., Ghofrani, Hossein A., Rummel, Sebastian, Wehner, Susan, Mühldorler, Inge, Scháfer, Klaus P., Seeger, Werner, Morty, Rory E., Grimminger, Friedrich, and Weissmann, Norbert
- Published
- 2008
- Full Text
- View/download PDF
12. APOPTOSIS CONTRIBUTES TO SEPTIC CARDIOMYOPATHY AND IS IMPROVED BY SIMVASTATIN THERAPY.
- Author
-
Buerke, Ute, Carter, Justin M., Schlitt, Axel, Russ, Martin, Schmidt, Hendrik, Sibelius, Ulf, Grandel, Ulrich, Grimminger, Friedrich, Seeger, Werner, Mueller-Werdan, Ursula, Werdan, Karl, and Buerke, Michael
- Published
- 2008
- Full Text
- View/download PDF
13. Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature.
- Author
-
Mittal, Manish, Roth, Markus, König, Peter, Hofmann, Simone, Dony, Eva, Goyal, Parag, Selbitz, Anne-Christin, Schermuly, Ralph Theo, Ghofrani, Hossein Ardeschir, Kwapiszewska, Grazyna, Kummer, Wolfgang, Klepetko, Walter, Hoda, Mir Ali Reza, Fink, Ludger, Hänze, Jörg, Seeger, Werner, Grimminger, Friedrich, Schmidt, Harald H.H.W., and Weissmann, Norbert
- Published
- 2007
- Full Text
- View/download PDF
14. Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells.
- Author
-
Olschewski, Andrea, Li, Yingji, Tang, Bi, Hanze, Jörg, Eul, Bastian, Bohle, Rainer M., Wilhelm, Jochen, Morty, Rory E., Brau, Michael E., Weir, E Kenneth, Kwapiszewska, Grazyna, Klepetko, Walter, Seeger, Werner, and Olschewski, Horst
- Published
- 2006
- Full Text
- View/download PDF
15. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.
- Author
-
Hattar K, Grandel U, Moeller A, Fink L, Iglhaut J, Hartung T, Morath S, Seeger W, Grimminger F, Sibelius U, Hattar, Katja, Grandel, Ulrich, Moeller, Alexander, Fink, Ludger, Iglhaut, Julia, Hartung, Thomas, Morath, Siegfried, Seeger, Werner, Grimminger, Friedrich, and Sibelius, Ulf
- Published
- 2006
- Full Text
- View/download PDF
16. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.
- Author
-
Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H, Stasch JP, Gnoth MJ, Seeger W, Grimminger F, Schermuly RT, Dumitrascu, Rio, Weissmann, Norbert, Ghofrani, Hossein Ardeschir, Dony, Eva, Beuerlein, Knut, Schmidt, Harald, Stasch, Johannes-Peter, Gnoth, Mark Jean, and Seeger, Werner
- Published
- 2006
17. Free arachidonic versus eicosapentaenoic acid differentially influences the potency of bacterial exotoxins to provoke myocardial depression in isolated rat hearts.
- Author
-
Grandel U, Benkelmann R, Buerke M, Kiss L, Hattar K, Mayer K, Heep M, Seeger W, Grimminger F, Sibelius U, Grandel, Ulrich, Benkelmann, Robin, Buerke, Michael, Kiss, Ladislau, Hattar, Katja, Mayer, Konstantin, Heep, Martina, Seeger, Werner, Grimminger, Friedrich, and Sibelius, Ulf
- Published
- 2006
- Full Text
- View/download PDF
18. Antiremodeling Effects of Iloprost and the Dual-Selective Phosphodiesterase 3/4 Inhibitor Tolafentrine in Chronic Experimental Pulmonary Hypertension.
- Author
-
Schermuly, Ralph Theo, Kreisselmeier, Klaus Peter, Ghofrani, Hossein Ardeschir, Samidurai, Arun, Pullamsetti, Soni, Weissmann, Norbert, Schudt, Christian, Ermert, Leander, Seeger, Werner, and Grimminger, Friedrich
- Published
- 2004
- Full Text
- View/download PDF
19. Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth.
- Author
-
Voswinckel, Robert, Ziegelhoeffer, Tibor, Heil, Matthias, Kostin, Sawa, Breier, Georg, Mehling, Tanja, Haberberger, Rainer, Clauss, Matthias, Gaumann, Andreas, Schaper, Wolfgang, and Seeger, Werner
- Published
- 2003
- Full Text
- View/download PDF
20. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
- Author
-
Schütte, Hartwig, Schell, Alexander, Schäfer, Christoph, Ghofrani, Ardeschir, Theo Schermuly, Ralph, Seeger, Werner, and Grimminger, Friedrich
- Published
- 2003
- Full Text
- View/download PDF
21. Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts.
- Author
-
Sibelius, Ulf, Grandel, Ulrich, Buerke, Michael, Kiss, Ladislau, Klingenberger, Pascal, Heep, Martina, Bournelis, Emmanoyil, Seeger, Werner, and Grimminger, Friedrich
- Published
- 2003
22. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.
- Author
-
Friedrich B, Schmidt R, Reiss I, Günther A, Seeger W, Müller M, Thul J, Schranz D, Gortner L, Friedrich, Bernd, Schmidt, Reinhold, Reiss, Irwin, Günther, Andreas, Seeger, Werner, Müller, Matthias, Thul, Joseph, Schranz, Dietmar, and Gortner, Ludwig
- Published
- 2003
- Full Text
- View/download PDF
23. Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension.
- Author
-
Ghofrani, Hossein A, Rose, Frank, Schermuly, Ralph T, Olschewski, Horst, Wiedemann, Ralph, Weissmann, Norbert, Schudt, Christian, Tenor, Herrmann, Seeger, Werner, and Grimminger, Friedrich
- Published
- 2002
24. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin.
- Author
-
Pruefer, Diethard, Makowski, Joachim, Schnell, Martin, Buerke, Ute, Dahm, Manfred, Oelert, Hellmut, Sibelius, Ulf, Grandel, Ulrich, Grimminger, Friedrich, Seeger, Werner, Meyer, Jürgen, Darius, Harald, and Buerke, Michael
- Published
- 2002
25. Adrenomedullin Reduces Endothelial Hyperpermeability.
- Author
-
Hippenstiel, Stefan, Witzenrath, Martin, Schmeck, Bernd, Hocke, Andreas, Krisp, Mathias, Krüll, Matthias, Seybold, Joachim, Seeger, Werner, Rascher, Wolfgang, Schütte, Hartwig, and Suttorp, Norbert
- Published
- 2002
26. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10.
- Author
-
Sibelius, Ulf, Hattar, Katja, Hoffmann, Sabine, Mayer, Konstantin, Grandel, Ulrich, Schenkel, Angelika, Seeger, Werner, and Grimminger, Friedrich
- Published
- 2002
27. Staphylococcus Aureus Alpha Toxin Mediates Polymorphonuclear Leukocyte-Induced Vasocontraction and Endothelial Dysfunction.
- Author
-
Buerke, Michael, Sibelius, Ulf, Grandel, Ulrich, Buerke, Ute, Grimminger, Friedrich, Seeger, Werner, Meyer, Jürgen, and Darius, Harald
- Published
- 2002
- Full Text
- View/download PDF
28. PROTECTION AGAINST GAS EXCHANGE ABNORMALITIES BY PRE-AEROSOLIZED PGE 1, ILOPROST AND NITROPRUSSIDE IN LUNG ISCHEMIA-REPERFUSION1.
- Author
-
Löckinger, Alexander, Schütte, Hartwig, Walmrath, Dieter, Seeger, Werner, and Grimminger, Friedrich
- Published
- 2001
- Full Text
- View/download PDF
29. Human Leukoagglutinating Antibody Evokes Cooperative Leukotriene Synthesis in Pulmonary Microvasculature.
- Author
-
Grimminger, Friedrich, Kreusler, Bettina, Schneider, Udo, Witzleben, Esther v., Walmrath, Dieter, Neppert, Jüirgen, and Seeger, Werner
- Published
- 1991
30. Pulmonary Vasoconstrictor Response to Soluble Fibrin in Isolated Lungs.
- Author
-
Seeger, Werner, Neuhof, Heinz, Hall, Johannes, and Roka, Ladislaus
- Published
- 1988
31. Altered Pulmonary Surfactant in Uncomplicated and Septicemia-Complicated Courses of Acute Respiratory Failure.
- Author
-
PISON, ULRICH, OBERTACKE, UDO, BRAND, MATTHIAS, SEEGER, WERNER, JOKA, THEO, BRUCH, JOACHIM, and SCHMIT-NEUERBURG, KLAUS PETER
- Published
- 1990
- Full Text
- View/download PDF
32. Response by Tello et al to Letter Regarding Article, "Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension".
- Author
-
Tello, Khodr, Ghofrani, Hossein A., Seeger, Werner, Richter, Manuel J., and Naeije, Robert
- Published
- 2019
- Full Text
- View/download PDF
33. Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.
- Author
-
Tello, Khodr, Wan, Jun, Dalmer, Antonia, Vanderpool, Rebecca, Ghofrani, Hossein A., Naeije, Robert, Roller, Fritz, Mohajerani, Emad, Seeger, Werner, Herberg, Ulrike, Sommer, Natascha, Gall, Henning, and Richter, Manuel J.
- Abstract
Supplemental Digital Content is available in the text. Background: The ratios of tricuspid annular plane systolic excursion (TAPSE)/echocardiographically measured systolic pulmonary artery pressure (PASP), fractional area change/invasively measured mean pulmonary artery pressure, right ventricular (RV) area change/end-systolic area, TAPSE/pulmonary artery acceleration time, and stroke volume/end-systolic area have been proposed as surrogates of RV-arterial coupling. The relationship of these surrogates with the gold standard measure of RV-arterial coupling (invasive pressure-volume loop-derived end-systolic/arterial elastance [Ees/Ea] ratio) and RV diastolic stiffness (end-diastolic elastance) in pulmonary hypertension remains incompletely understood. We evaluated the relationship of these surrogates with invasive pressure-volume loop-derived Ees/Ea and end-diastolic elastance in pulmonary hypertension. Methods: We performed right heart echocardiography and cardiac magnetic resonance imaging 1 day before invasive measurement of pulmonary hemodynamics and single-beat RV pressure-volume loops in 52 patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. The relationships of the proposed surrogates with Ees/Ea and end-diastolic elastance were evaluated by Spearman correlation, multivariate logistic regression, and receiver operating characteristic analyses. Associations with prognosis were evaluated by Kaplan-Meier analysis. Results: TAPSE/PASP, fractional area change/mean pulmonary artery pressure, RV area change/end-systolic area, and stroke volume/end-systolic area but not TAPSE/pulmonary artery acceleration time were correlated with Ees/Ea and end-diastolic elastance. Of the surrogates, only TAPSE/PASP emerged as an independent predictor of Ees/Ea (multivariate odds ratio: 18.6; 95% CI, 0.8–96.1; P =0.08). In receiver operating characteristic analysis, a TAPSE/PASP cutoff of 0.31 mm/mm Hg (sensitivity: 87.5% and specificity: 75.9%) discriminated RV-arterial uncoupling (Ees/Ea <0.805). Patients with TAPSE/PASP <0.31 mm/mm Hg had a significantly worse prognosis than those with higher TAPSE/PASP. Conclusions: Echocardiographically determined TAPSE/PASP is a straightforward noninvasive measure of RV-arterial coupling and is affected by RV diastolic stiffness in severe pulmonary hypertension. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03403868. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
34. Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload.
- Author
-
Tello, Khodr, Dalmer, Antonia, Axmann, Jens, Vanderpool, Rebecca, Ghofrani, Hossein A., Naeije, Robert, Roller, Fritz, Seeger, Werner, Sommer, Natascha, Wilhelm, Jochen, Gall, Henning, and Richter, Manuel J.
- Abstract
Supplemental Digital Content is available in the text. Background: Right ventricular (RV) maladaptation and failure determine outcome in pulmonary hypertension. The adaptation of RV function to loading (RV-pulmonary arterial coupling) is defined by a ratio of end-systolic to arterial elastances (Ees/Ea). How RV-pulmonary arterial coupling relates to pulmonary hypertension severity and onset of RV failure (defined by excessive volume increase and ejection fraction [EF] decrease) is not exactly known. Methods and Results: We performed cardiac magnetic resonance (CMR) imaging within 24 hours of a diagnostic right heart catheterization and invasive measurement of RV pressure-volume loops in 42 patients with pulmonary hypertension. Median (interquartile range) Ees and Ea were 0.49 (0.35–0.74) and 0.74 (0.45–1.04) mm Hg/mL, respectively; Ees/Ea was 0.73 (0.47–1.07). End-diastolic elastance (Eed) was 0.14 (0.06–0.24) mm Hg/mL. RV EF was 39±13%. End-systolic volume and end-diastolic volume/body surface area (BSA) were 62 (45–101) and 104 (83–143) mL/m
2 , respectively. Ees/Ea decreased with increasing RV end-diastolic volume/BSA, mass/BSA, and pulmonary arterial stiffness, and with decreasing EF, from 0.89 to 1.09 in the least impaired tertiles to 0.55 to 0.61 in the most impaired tertiles. Eed increased with increasing RV mass/BSA, end-diastolic volume/BSA, and T1 mapping and with decreasing EF. Receiver operating characteristic analysis identified an Ees/Ea cutoff of 0.805 associated with onset of RV failure defined by increased RV volumes with EF <35%. Conclusions: RV-pulmonary arterial coupling (Ees/Ea) has considerable reserve, from normal values of 1.5–2 to <0.8, and has the ability to detect pending RV failure in patients with pulmonary hypertension. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03403868. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
35. Evaluating Systolic and Diastolic Cardiac Function in Rodents Using Microscopic Computed Tomography.
- Author
-
Kojonazarov, Baktybek, Belenkov, Alexander, Shinomiya, Shohei, Wilchelm, Jochen, Kampschulte, Marian, Mizuno, Shiro, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Weissmann, Norbert, Seeger, Werner, and Schermuly, Ralph Theo
- Abstract
Supplemental Digital Content is available in the text. Background: The use of microscopic computed tomography to assess the key functional parameters of systolic emptying or diastolic filling in small animals has not been previously reported. The aim of the study was to test whether microscopic computed tomography can assess the dynamics of both left ventricle and right ventricle (RV) diastolic filling and systolic emptying in an experimental model of pulmonary arterial hypertension Methods and Results: The Wistar-Kyoto rats were injected subcutaneously with the VEGF (vascular endothelial growth factor)-receptor inhibitor SU5416 (20 mg/kg body weight) and were then exposed to chronic hypoxia (10% oxygen) for 21 days (SU5416-hypoxia) followed by normoxia for an additional 2 weeks. Thereafter, multiphase cine cardiac images were acquired using a microscopic computed tomography scanner in conjunction with a blood-pool iodinated contrast agent. Examination of the 3-dimensional images of SU5416-hypoxia rats confirmed the presence of severe pulmonary arterial hypertension. Functional parameters that describe the dynamics of ventricular systolic ejection and diastolic filling were calculated. RV peak ejection rate was significantly decreased (P <0.03) in SU5416-hypoxia rats compared with controls. RV peak filling rate had a significant decrease compared with controls (P <0.03), particularly in the early phase of diastole (P <0.03). This was accompanied by increased time to peak filling rate (P <0.03) and total filling time (P <0.06). Spearman analysis between microscopic computed tomography RV diastolic indices and invasively derived RV end-diastolic pressure indicated excellent correlation. Conclusions: We developed a method that allows rapid and accurate assessment of cardiac functional indices and that paves the way for more extensive preclinical cardiovascular research. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
36. GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension.
- Author
-
Chu X, Kheirollahi V, Lingampally A, Chelladurai P, Valasarajan C, Vazquez-Armendariz AI, Hadzic S, Khadim A, Pak O, Rivetti S, Wilhelm J, Bartkuhn M, Crnkovic S, Moiseenko A, Heiner M, Kraut S, Atefi LS, Koepke J, Valente G, Ruppert C, Braun T, Samakovlis C, Alexopoulos I, Looso M, Chao CM, Herold S, Seeger W, Kwapiszewska G, Huang X, Zhang JS, Pullamsetti SS, Weissmann N, Li X, El Agha E, and Bellusci S
- Subjects
- Animals, Mice, Muscle, Smooth, Vascular metabolism, Muscle, Smooth, Vascular pathology, Myocytes, Smooth Muscle metabolism, Myocytes, Smooth Muscle pathology, Mice, Inbred C57BL, Pulmonary Artery metabolism, Pulmonary Artery pathology, Pulmonary Artery physiopathology, Mice, Transgenic, Male, Humans, Hypoxia metabolism, Hypoxia physiopathology, Zinc Finger Protein GLI1 metabolism, Zinc Finger Protein GLI1 genetics, Vascular Remodeling, Hypertension, Pulmonary metabolism, Hypertension, Pulmonary physiopathology, Hypertension, Pulmonary pathology
- Abstract
Background: The precise origin of newly formed ACTA2+ (alpha smooth muscle actin-positive) cells appearing in nonmuscularized vessels in the context of pulmonary hypertension is still debatable although it is believed that they predominantly derive from preexisting vascular smooth muscle cells (VSMCs)., Methods: Gli1
Cre-ERT2 ; tdTomatoflox mice were used to lineage trace GLI1+ (glioma-associated oncogene homolog 1-positive) cells in the context of pulmonary hypertension using 2 independent models of vascular remodeling and reverse remodeling: hypoxia and cigarette smoke exposure. Hemodynamic measurements, right ventricular hypertrophy assessment, flow cytometry, and histological analysis of thick lung sections followed by state-of-the-art 3-dimensional reconstruction and quantification using Imaris software were used to investigate the contribution of GLI1+ cells to neomuscularization of the pulmonary vasculature., Results: The data show that GLI1+ cells are abundant around distal, nonmuscularized vessels during steady state, and this lineage contributes to around 50% of newly formed ACTA2+ cells around these normally nonmuscularized vessels. During reverse remodeling, cells derived from the GLI1+ lineage are largely cleared in parallel to the reversal of muscularization. Partial ablation of GLI1+ cells greatly prevented vascular remodeling in response to hypoxia and attenuated the increase in right ventricular systolic pressure and right heart hypertrophy. Single-cell RNA sequencing on sorted lineage-labeled GLI1+ cells revealed an Acta2high fraction of cells with pathways in cancer and MAPK (mitogen-activated protein kinase) signaling as potential players in reprogramming these cells during vascular remodeling. Analysis of human lung-derived material suggests that GLI1 signaling is overactivated in both group 1 and group 3 pulmonary hypertension and can promote proliferation and myogenic differentiation., Conclusions: Our data highlight GLI1+ cells as an alternative cellular source of VSMCs in pulmonary hypertension and suggest that these cells and the associated signaling pathways represent an important therapeutic target for further studies., Competing Interests: Disclosures None.- Published
- 2024
- Full Text
- View/download PDF
37. Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
- Author
-
Nayakanti SR, Friedrich A, Sarode P, Jafari L, Maroli G, Boehm M, Bourgeois A, Grobs Y, Khassafi F, Kuenne C, Guenther S, Dabral S, Wilhelm J, Weiss A, Wietelmann A, Kojonazarov B, Janssen W, Looso M, de Man F, Provencher S, Tello K, Seeger W, Bonnet S, Savai R, Schermuly RT, and Pullamsetti SS
- Subjects
- Rats, Mice, Animals, Ventricular Remodeling, beta Catenin, Catenins, Monocrotaline toxicity, Signal Transduction, Disease Models, Animal, Ventricular Function, Right, Pulmonary Arterial Hypertension, Heart Failure
- Abstract
Background: The ability of the right ventricle (RV) to adapt to an increased pressure afterload determines survival in patients with pulmonary arterial hypertension. At present, there are no specific treatments available to prevent RV failure, except for heart/lung transplantation. The wingless/int-1 (Wnt) signaling pathway plays an important role in the development of the RV and may also be implicated in adult cardiac remodeling., Methods: Molecular, biochemical, and pharmacological approaches were used both in vitro and in vivo to investigate the role of Wnt signaling in RV remodeling., Results: Wnt/β-catenin signaling molecules are upregulated in RV of patients with pulmonary arterial hypertension and animal models of RV overload (pulmonary artery banding-induced and monocrotaline rat models). Activation of Wnt/β-catenin signaling leads to RV remodeling via transcriptional activation of FOSL1 and FOSL2 (FOS proto-oncogene [FOS] like 1/2, AP-1 [activator protein 1] transcription factor subunit). Immunohistochemical analysis of pulmonary artery banding -exposed BAT-Gal (β-catenin-activated transgene driving expression of nuclear β-galactosidase) reporter mice RVs exhibited an increase in β-catenin expression compared with their respective controls. Genetic inhibition of β-catenin, FOSL1/2, or WNT3A stimulation of RV fibroblasts significantly reduced collagen synthesis and other remodeling genes. Importantly, pharmacological inhibition of Wnt signaling using inhibitor of PORCN (porcupine O-acyltransferase), LGKK-974 attenuated fibrosis and cardiac hypertrophy leading to improvement in RV function in both, pulmonary artery banding - and monocrotaline-induced RV overload., Conclusions: Wnt- β-Catenin-FOSL signaling is centrally involved in the hypertrophic RV response to increased afterload, offering novel targets for therapeutic interference with RV failure in pulmonary hypertension., Competing Interests: Disclosures None.
- Published
- 2023
- Full Text
- View/download PDF
38. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
- Author
-
Veith C, Vartürk-Özcan I, Wujak M, Hadzic S, Wu CY, Knoepp F, Kraut S, Petrovic A, Gredic M, Pak O, Brosien M, Heimbrodt M, Wilhelm J, Weisel FC, Malkmus K, Schäfer K, Gall H, Tello K, Kosanovic D, Sydykov A, Sarybaev A, Günther A, Brandes RP, Seeger W, Grimminger F, Ghofrani HA, Schermuly RT, Kwapiszewska G, Sommer N, and Weissmann N
- Subjects
- Animals, Cell Proliferation, Cells, Cultured, Endothelial Cells metabolism, Familial Primary Pulmonary Hypertension metabolism, Humans, Hypoxia metabolism, Mice, Mice, Inbred C57BL, Myocytes, Smooth Muscle metabolism, Osteonectin genetics, Pulmonary Artery, Vascular Remodeling genetics, Hypertension, Pulmonary pathology
- Abstract
Background: Pulmonary hypertension (PH) is a life-threatening disease, characterized by excessive pulmonary vascular remodeling, leading to elevated pulmonary arterial pressure and right heart hypertrophy. PH can be caused by chronic hypoxia, leading to hyper-proliferation of pulmonary arterial smooth muscle cells (PASMCs) and apoptosis-resistant pulmonary microvascular endothelial cells (PMVECs). On reexposure to normoxia, chronic hypoxia-induced PH in mice is reversible. In this study, the authors aim to identify novel candidate genes involved in pulmonary vascular remodeling specifically in the pulmonary vasculature., Methods: After microarray analysis, the authors assessed the role of SPARC (secreted protein acidic and rich in cysteine) in PH using lung tissue from idiopathic pulmonary arterial hypertension (IPAH) patients, as well as from chronically hypoxic mice. In vitro studies were conducted in primary human PASMCs and PMVECs. In vivo function of SPARC was proven in chronic hypoxia-induced PH in mice by using an adeno-associated virus-mediated Sparc knockdown approach., Results: C57BL/6J mice were exposed to normoxia, chronic hypoxia, or chronic hypoxia with subsequent reexposure to normoxia for different time points. Microarray analysis of the pulmonary vascular compartment after laser microdissection identified Sparc as one of the genes downregulated at all reoxygenation time points investigated. Intriguingly, SPARC was vice versa upregulated in lungs during development of hypoxia-induced PH in mice as well as in IPAH, although SPARC plasma levels were not elevated in PH. TGF-β1 (transforming growth factor β1) or HIF2A (hypoxia-inducible factor 2A) signaling pathways induced SPARC expression in human PASMCs. In loss of function studies, SPARC silencing enhanced apoptosis and reduced proliferation. In gain of function studies, elevated SPARC levels induced PASMCs, but not PMVECs, proliferation. Coculture and conditioned medium experiments revealed that PMVECs-secreted SPARC acts as a paracrine factor triggering PASMCs proliferation. Contrary to the authors' expectations, in vivo congenital Sparc knockout mice were not protected from hypoxia-induced PH, most probably because of counter-regulatory proproliferative signaling. However, adeno-associated virus-mediated Sparc knockdown in adult mice significantly improved hemodynamic and cardiac function in PH mice., Conclusions: This study provides evidence for the involvement of SPARC in the pathogenesis of human PH and chronic hypoxia-induced PH in mice, most likely by affecting vascular cell function.
- Published
- 2022
- Full Text
- View/download PDF
39. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
- Author
-
Kudryashova TV, Dabral S, Nayakanti S, Ray A, Goncharov DA, Avolio T, Shen Y, Rode A, Pena A, Jiang L, Lin D, Baust J, Bachman TN, Graumann J, Ruppert C, Guenther A, Schmoranzer M, Grobs Y, Eve Lemay S, Tremblay E, Breuils-Bonnet S, Boucherat O, Mora AL, DeLisser H, Zhao J, Zhao Y, Bonnet S, Seeger W, Pullamsetti SS, and Goncharova EA
- Subjects
- Animals, Cell Proliferation, Cells, Cultured, Hypoxia metabolism, Mammals, Mechanistic Target of Rapamycin Complex 1 metabolism, Mice, Myocytes, Smooth Muscle metabolism, Proteomics, Proto-Oncogene Proteins c-akt metabolism, Pulmonary Artery metabolism, Vascular Remodeling physiology, Cell Cycle Proteins metabolism, Chromosomal Proteins, Non-Histone metabolism, Forkhead Transcription Factors metabolism, Hypertension, Pulmonary metabolism, Poly-ADP-Ribose Binding Proteins metabolism, Pulmonary Arterial Hypertension genetics
- Abstract
Rationale: The MSTs (mammalian Ste20-like kinases) 1/2 are members of the HIPPO pathway that act as growth suppressors in adult proliferative diseases. Pulmonary arterial hypertension (PAH) manifests by increased proliferation and survival of pulmonary vascular cells in small PAs, pulmonary vascular remodeling, and the rise of pulmonary arterial pressure. The role of MST1/2 in PAH is currently unknown., Objective: To investigate the roles and mechanisms of the action of MST1 and MST2 in PAH., Methods and Results: Using early-passage pulmonary vascular cells from PAH and nondiseased lungs and mice with smooth muscle-specific tamoxifen-inducible Mst1/2 knockdown, we found that, in contrast to canonical antiproliferative/proapoptotic roles, MST1/2 act as proproliferative/prosurvival molecules in human PAH pulmonary arterial vascular smooth muscle cells and pulmonary arterial adventitial fibroblasts and support established pulmonary vascular remodeling and pulmonary hypertension in mice with SU5416/hypoxia-induced pulmonary hypertension. By using unbiased proteomic analysis, gain- and loss-of function approaches, and pharmacological inhibition of MST1/2 kinase activity by XMU-MP-1, we next evaluated mechanisms of regulation and function of MST1/2 in PAH pulmonary vascular cells. We found that, in PAH pulmonary arterial adventitial fibroblasts, the proproliferative function of MST1/2 is caused by IL-6-dependent MST1/2 overexpression, which induces PSMC6-dependent downregulation of forkhead homeobox type O 3 and hyperproliferation. In PAH pulmonary arterial vascular smooth muscle cells, MST1/2 acted via forming a disease-specific interaction with BUB3 and supported ECM (extracellular matrix)- and USP10-dependent BUB3 accumulation, upregulation of Akt-mTORC1, cell proliferation, and survival. Supporting our in vitro observations, smooth muscle-specific Mst1/2 knockdown halted upregulation of Akt-mTORC1 in small muscular PAs of mice with SU5416/hypoxia-induced pulmonary hypertension., Conclusions: Together, this study describes a novel proproliferative/prosurvival role of MST1/2 in PAH pulmonary vasculature, provides a novel mechanistic link from MST1/2 via BUB3 and forkhead homeobox type O to the abnormal proliferation and survival of pulmonary arterial vascular smooth muscle cells and pulmonary arterial adventitial fibroblasts, remodeling and pulmonary hypertension, and suggests new target pathways for therapeutic intervention.
- Published
- 2022
- Full Text
- View/download PDF
40. Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension.
- Author
-
Swietlik EM, Greene D, Zhu N, Megy K, Cogliano M, Rajaram S, Pandya D, Tilly T, Lutz KA, Welch CCL, Pauciulo MW, Southgate L, Martin JM, Treacy CM, Penkett CJ, Stephens JC, Bogaard HJ, Church C, Coghlan G, Coleman AW, Condliffe R, Eichstaedt CA, Eyries M, Gall H, Ghio S, Girerd B, Grünig E, Holden S, Howard L, Humbert M, Kiely DG, Kovacs G, Lordan J, Machado RD, Mackenzie Ross RV, McCabe C, Moledina S, Montani D, Olschewski H, Pepke-Zaba J, Price L, Rhodes CJ, Seeger W, Soubrier F, Suntharalingam J, Toshner MR, Vonk Noordegraaf A, Wharton J, Wild JM, Wort SJ, Lawrie A, Wilkins MR, Trembath RC, Shen Y, Chung WK, Swift AJ, Nichols WC, Morrell NW, and Gräf S
- Abstract
Background - Approximately 25% of patients with pulmonary arterial hypertension (PAH) have been found to harbor rare mutations in disease-causing genes. To identify missing heritability in PAH we integrated deep phenotyping with whole-genome sequencing data using Bayesian statistics. Methods - We analyzed 13,037 participants enrolled in the NIHR BioResource - Rare Diseases (NBR) study, of which 1,148 were recruited to the PAH domain. To test for genetic associations between genes and selected phenotypes of pulmonary hypertension (PH), we used the Bayesian rare-variant association method BeviMed. Results - Heterozygous, high impact, likely loss-of-function variants in the Kinase Insert Domain Receptor ( KDR ) gene were strongly associated with significantly reduced transfer coefficient for carbon monoxide (KCO, posterior probability (PP)=0.989) and older age at diagnosis (PP=0.912). We also provide evidence for familial segregation of a rare nonsense KDR variant with these phenotypes. On computed tomographic imaging of the lungs, a range of parenchymal abnormalities were observed in the five patients harboring these predicted deleterious variants in KDR . Four additional PAH cases with rare likely loss-of-function variants in KDR were independently identified in the US PAH Biobank cohort with similar phenotypic characteristics. Conclusions - The Bayesian inference approach allowed us to independently validate KDR , which encodes for the Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), as a novel PAH candidate gene. Furthermore, this approach specifically associated high impact likely loss-of-function variants in the genetically constrained gene with distinct phenotypes. These findings provide evidence for KDR being a clinically actionable PAH gene and further support the central role of the vascular endothelium in the pathobiology of PAH.
- Published
- 2020
- Full Text
- View/download PDF
41. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
- Author
-
Nave AH, Mižíková I, Niess G, Steenbock H, Reichenberger F, Talavera ML, Veit F, Herold S, Mayer K, Vadász I, Weissmann N, Seeger W, Brinckmann J, and Morty RE
- Subjects
- Adult, Aged, 80 and over, Animals, Antihypertensive Agents pharmacology, Case-Control Studies, Cell Hypoxia, Cells, Cultured, Collagen metabolism, Disease Models, Animal, Elastin metabolism, Enzyme Inhibitors pharmacology, Familial Primary Pulmonary Hypertension, Female, Fibroblasts enzymology, Fibroblasts pathology, Gene Expression Regulation, Enzymologic, Humans, Hypertension, Pulmonary drug therapy, Hypertension, Pulmonary etiology, Hypertension, Pulmonary genetics, Hypertension, Pulmonary pathology, Hypertrophy, Right Ventricular enzymology, Hypertrophy, Right Ventricular etiology, Hypertrophy, Right Ventricular prevention & control, Hypoxia complications, Isoenzymes, Male, Mice, Middle Aged, Monocrotaline, Muscle, Smooth, Vascular enzymology, Muscle, Smooth, Vascular pathology, Myocytes, Smooth Muscle enzymology, Myocytes, Smooth Muscle pathology, Protein-Lysine 6-Oxidase antagonists & inhibitors, Protein-Lysine 6-Oxidase genetics, Pulmonary Artery drug effects, Pulmonary Artery pathology, RNA, Messenger metabolism, Rats, Ventricular Dysfunction, Right enzymology, Ventricular Dysfunction, Right etiology, Ventricular Dysfunction, Right physiopathology, Ventricular Dysfunction, Right prevention & control, Young Adult, Hypertension, Pulmonary enzymology, Protein-Lysine 6-Oxidase metabolism, Pulmonary Artery enzymology
- Abstract
Objective: Pulmonary vascular remodeling, the pathological hallmark of pulmonary arterial hypertension, is attributed to proliferation, apoptosis resistance, and migration of vascular cells. A role of dysregulated matrix cross-linking and stability as a pathogenic mechanism has received little attention. We aimed to assess whether matrix cross-linking enzymes played a causal role in experimental pulmonary hypertension (PH)., Approach and Results: All 5 lysyl oxidases were detected in concentric and plexiform vascular lesions of patients with idiopathic pulmonary arterial hypertension. Lox, LoxL1, LoxL2, and LoxL4 expression was elevated in lungs of patients with idiopathic pulmonary arterial hypertension, whereas LoxL2 and LoxL3 expression was elevated in laser-capture microdissected vascular lesions. Lox expression was hypoxia-responsive in pulmonary artery smooth muscle cells and adventitial fibroblasts, whereas LoxL1 and LoxL2 expression was hypoxia-responsive in adventitial fibroblasts. Lox expression was increased in lungs from hypoxia-exposed mice and in lungs and pulmonary artery smooth muscle cells of monocrotaline-treated rats, which developed PH. Pulmonary hypertensive mice exhibited increased muscularization and perturbed matrix structures in vessel walls of small pulmonary arteries. Hypoxia exposure led to increased collagen cross-linking, by dihydroxylysinonorleucine and hydroxylysinonorleucine cross-links. Administration of the lysyl oxidase inhibitor β-aminopropionitrile attenuated the effect of hypoxia, limiting perturbations to right ventricular systolic pressure, right ventricular hypertrophy, and vessel muscularization and normalizing collagen cross-linking and vessel matrix architecture., Conclusions: Lysyl oxidases are dysregulated in clinical and experimental PH. Lysyl oxidases play a causal role in experimental PH and represent a candidate therapeutic target. Our proof-of-principle study demonstrated that modulation of lung matrix cross-linking can affect pulmonary vascular remodeling associated with PH., (© 2014 American Heart Association, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
42. Role of Src tyrosine kinases in experimental pulmonary hypertension.
- Author
-
Pullamsetti SS, Berghausen EM, Dabral S, Tretyn A, Butrous E, Savai R, Butrous G, Dahal BK, Brandes RP, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Rosenkranz S, and Schermuly RT
- Subjects
- Animals, Apoptosis drug effects, Becaplermin, Benzamides, Cell Proliferation drug effects, Cells, Cultured, Chemotaxis drug effects, Dasatinib, Disease Models, Animal, Dose-Response Relationship, Drug, Hemodynamics, Humans, Hypertension, Pulmonary enzymology, Hypertension, Pulmonary etiology, Hypertension, Pulmonary pathology, Hypertension, Pulmonary physiopathology, Hypertrophy, Right Ventricular enzymology, Hypertrophy, Right Ventricular pathology, Hypertrophy, Right Ventricular prevention & control, Hypoxia complications, Imatinib Mesylate, Monocrotaline, Muscle, Smooth, Vascular enzymology, Muscle, Smooth, Vascular pathology, Muscle, Smooth, Vascular physiopathology, Myocytes, Smooth Muscle enzymology, Myocytes, Smooth Muscle pathology, Phosphorylation, Piperazines pharmacology, Proteins pharmacology, Proto-Oncogene Proteins c-akt metabolism, Proto-Oncogene Proteins c-sis metabolism, Pyrimidines pharmacology, Rats, Receptor, Platelet-Derived Growth Factor beta antagonists & inhibitors, Receptor, Platelet-Derived Growth Factor beta metabolism, STAT3 Transcription Factor metabolism, Signal Transduction drug effects, Thiazoles pharmacology, Time Factors, src-Family Kinases metabolism, Hypertension, Pulmonary drug therapy, Muscle, Smooth, Vascular drug effects, Myocytes, Smooth Muscle drug effects, Protein Kinase Inhibitors pharmacology, src-Family Kinases antagonists & inhibitors
- Abstract
Objective: Pulmonary arterial hypertension is a progressive pulmonary vascular disorder with high morbidity and mortality. Compelling evidence suggests that receptor tyrosine kinases, such as platelet-derived growth factor (PDGF) are closely involved in the pathogenesis of pulmonary arterial hypertension. We investigated the effects of 2 novel PDGF inhibitors, nilotinib/AMN107 (Abl kinases/PDGF receptor inhibitor) and dasatinib/BMS-354825 (Abl kinases/PDGF receptor/Src inhibitor), on the proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) and on the hemodynamics and pulmonary vascular remodeling in experimental pulmonary hypertension, and determined the expression and regulation of Src family kinases., Methods and Results: Human PASMCs were stimulated by PDGF alone or multiple growth factors to induce proliferation and migration in vitro. Dasatinib (0.03 μmol/L), nilotinib (0.3 μmol/L), and imatinib (1 μmol/L) potently inhibited PDGF-induced signal transducer and activator of transcription 3 and Akt phosphorylation. All 3 inhibitors decreased PDGF-induced proliferation, cell cycle gene regulation, and migration. In contrast, only dasatinib inhibited multiple growth factor-induced PASMC proliferation, and this was associated with the inhibition of Src phosphorylation. Combination of specific Src inhibitors (phosphoprotein phosphatase 1, phosphoprotein phosphatase 2) with either imatinib or nilotinib reduced multiple growth factor-induced proliferation to a similar extent as dasatinib. Importantly, Src phosphorylation increased in pulmonary arterial hypertension PASMCs compared with control PASMCs. Finally, in vivo dasatinib (15 mg/kg per body weight) treatment caused a complete reversal of pulmonary vascular remodeling and achieved similar effectiveness as imatinib (100 mg/kg per body weight) in both monocrotaline- and hypoxia-induced pulmonary hypertension models., Conclusions: We suggest that dual inhibition of PDGF receptor and Src kinases potently inhibits mitogenic and motogenic responses to growth factors in PASMCs and pulmonary vascular remodeling in vivo so that dual inhibition may represent an alternative therapeutic approach for pulmonary arterial hypertension.
- Published
- 2012
- Full Text
- View/download PDF
43. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.
- Author
-
Pullamsetti SS, Savai R, Schaefer MB, Wilhelm J, Ghofrani HA, Weissmann N, Schudt C, Fleming I, Mayer K, Leiper J, Seeger W, Grimminger F, and Schermuly RT
- Subjects
- 3',5'-Cyclic-AMP Phosphodiesterases metabolism, Amidohydrolases antagonists & inhibitors, Amidohydrolases genetics, Apoptosis drug effects, Arginine analogs & derivatives, Arginine antagonists & inhibitors, Arginine metabolism, Cell Proliferation drug effects, Cell Survival drug effects, Cells, Cultured, Cyclic GMP biosynthesis, Cytokines pharmacology, Endothelial Cells drug effects, Endothelial Cells enzymology, Endothelial Cells physiology, Hemodynamics drug effects, Humans, Phosphodiesterase Inhibitors, Promoter Regions, Genetic, Pulmonary Gas Exchange drug effects, 3',5'-Cyclic-AMP Phosphodiesterases antagonists & inhibitors, Hypertension, Pulmonary drug therapy, Naphthyridines pharmacology, Nitric Oxide biosynthesis
- Abstract
Background: Pulmonary arterial hypertension is characterized by a progressive increase in pulmonary vascular resistance caused by endothelial dysfunction, inward vascular remodeling, and severe loss of precapillary pulmonary vessel cross-sectional area. Asymmetrical dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and its metabolizing enzyme dimethylarginine dimethylaminohydrolase (DDAH) play important roles in endothelial dysfunction. We investigated whether combined phosphodiesterase (PDE) 3 and 4 inhibition ameliorates endothelial function by regulating the ADMA-DDAH axis., Methods and Results: We investigated the effects of the PDE3/4 inhibitor tolafentrine in vitro on endothelial cell survival, proliferation, and apoptosis. Effects of tolafentrine on the endothelial nitric oxide synthase/nitric oxide pathway, DDAH expression, DDAH promoter activity, and cytokine release from endothelial cells and their subsequent influence on DDAH expression were investigated. In monocrotaline-induced pulmonary arterial hypertension in rats, the effects of inhaled tolafentrine on DDAH expression and activity were investigated. Real-time-polymerase chain reaction, immunocytochemistry, and PDE activity assays suggested high expression of PDE3 and PDE4 isoforms in endothelial cells. Treatment of endothelial cells with PDE3/4 inhibitor significantly decreased ADMA-induced apoptosis via a cAMP/PKA-dependent pathway by induction of DDAH2. Chronic nebulization of PDE3/4 inhibitor significantly attenuated monocrotaline-induced hemodynamic, gas exchange abnormalities, vascular remodeling, and right heart hypertrophy. Interestingly, PDE3/4 inhibitor treatment reduced ADMA and elevated nitric oxide/cGMP levels. Mechanistically, this could be attributed to direct modulatory effects of cAMP on the promoter region of DDAH2, which was consequently found to be increased in expression and activity. Furthermore, PDE3/4 inhibitor suppressed apoptosis in endothelial cells and increased vascularization in the lung., Conclusion: Combined inhibition of PDE3 and 4 regresses development of pulmonary hypertension and promotes endothelial regeneration by modulating the ADMA-DDAH axis.
- Published
- 2011
- Full Text
- View/download PDF
44. Staphylococcus aureus alpha-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts.
- Author
-
Grandel U, Bennemann U, Buerke M, Hattar K, Seeger W, Grimminger F, and Sibelius U
- Subjects
- Animals, In Vitro Techniques, Male, Rats, Rats, Wistar, Bacterial Toxins pharmacology, Coronary Circulation drug effects, Eicosanoids metabolism, Escherichia coli Proteins pharmacology, Hemolysin Proteins pharmacology, Myocardial Contraction drug effects, Myocardium metabolism
- Abstract
Objective: In sepsis, cardiac function is frequently depressed. Microcirculatory disturbances as evidenced in most organs may extend to the coronary circulation and may play a role in the occurrence of cardiac dysfunction. Staphylococcal alpha-toxin and Escherichia coli hemolysin (ECH), pore-forming exotoxins of clinically relevant bacteria, have recently been demonstrated to evoke cardiac dysfunction in isolated rat hearts by activating myocardial eicosanoid metabolism. alpha-Toxin activates synthesis of thromboxane (Tx) A2, ECH of cysteinyl-leukotrienes (Sibelius U, Grandel U, Buerke M, et al: Leukotriene-mediated coronary vasoconstriction and loss in myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused reat hearts. Crit Care Med 2003; 3:683-688, Sibelius U, Grandel U, Buerke M, et al: Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts-Role of Tx formation. Circulation 2000; 101:78-85). We now investigated whether cardiac dysfunction in response to alpha-toxin and ECH is caused by disturbances of regional cardiac perfusion., Design: A prospective, experimental study., Setting: A research laboratory at a university hospital., Subjects: Isolated hearts from male Wistar rats., Interventions: Changes of regional perfusion were investigated by using colored microspheres in isolated rat hearts perfused with alpha-toxin or ECH either at constant coronary perfusion pressure or constant coronary flow rate. Significance of toxin-activated eicosanoid generation was evaluated by pharmacologic interventions., Measurements and Main Results: By eliciting eicosanoid formation, both toxins caused an increase in coronary vascular resistance and a loss in contractile function. In ECH-perfused hearts, reduction of regional perfusion predominantly occurred in subendocardial sections in either perfusion mode (coronary perfusion pressure or coronary flow rate). When synthesis of cysteinyl-leukotrienes was blocked by the 5-lipooxygenase inhibitor MK-886, disturbances of regional perfusion and the associated cardiac dysfunction were largely prevented. Coronary perfusion of alpha-toxin caused a decrease of regional perfusion that was more pronounced in subepicardial layers. Inhibiting the release of TxA2 by blocking the cyclooxygenase with indomethacin attenuated the perfusion abnormalities and the cardiodepression in response to alpha-toxin., Conclusions: Bacterial exotoxins of clinically relevant bacteria may impair cardiac function by eliciting distinct coronary perfusion abnormalities via release of vasoactive eicosanoids.
- Published
- 2009
- Full Text
- View/download PDF
45. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.
- Author
-
Grünig E, Weissmann S, Ehlken N, Fijalkowska A, Fischer C, Fourme T, Galié N, Ghofrani A, Harrison RE, Huez S, Humbert M, Janssen B, Kober J, Koehler R, Machado RD, Mereles D, Naeije R, Olschewski H, Provencher S, Reichenberger F, Retailleau K, Rocchi G, Simonneau G, Torbicki A, Trembath R, and Seeger W
- Subjects
- Adult, Blood Pressure physiology, Europe, Exercise physiology, Exercise Test, Family, Female, Heart Rate physiology, Humans, Hypertension genetics, Hypertension physiopathology, Hypertension, Pulmonary physiopathology, Hypoxia genetics, Hypoxia physiopathology, Male, Middle Aged, Prospective Studies, Rest physiology, Tricuspid Valve Insufficiency physiopathology, Young Adult, Bone Morphogenetic Protein Receptors, Type II genetics, Echocardiography, Doppler, Hypertension, Pulmonary diagnostic imaging, Hypertension, Pulmonary genetics, Tricuspid Valve Insufficiency diagnostic imaging, Tricuspid Valve Insufficiency genetics
- Abstract
Background: This large, prospective, multicentric study was performed to analyze the distribution of tricuspid regurgitation velocity (TRV) values during exercise and hypoxia in relatives of patients with idiopathic and familial pulmonary arterial hypertension (PAH) and in healthy control subjects. We tested the hypothesis that relatives of idiopathic/familial PAH patients display an enhanced frequency of hypertensive TRV response to stress and that this response is associated with mutations in the bone morphogenetic protein receptor II (BMPR2) gene., Methods and Results: TRV was estimated by Doppler echocardiography during supine bicycle exercise in normoxia and during 120 minutes of normobaric hypoxia (FIO(2)=12%; approximately 4500 m) in 291 relatives of 109 PAH patients and in 191 age-matched control subjects. Mean maximal TRVs were significantly higher in PAH relatives during both exercise and hypoxia. During exercise, 10% of control subjects but 31.6% of relatives (P<0.0001) exceeded the 90% quantile of mean maximal TRV seen in control subjects. Hypoxia revealed hypertensive TRV in 26% of relatives (P=0.0029). Among control subjects, TRV at rest was not related to age, sex, body mass index, systemic blood pressure, smoking status, or heart rate. Within kindreds identified as harboring deleterious mutations of the BMPR2 gene, a hypertensive TRV response occurred significantly more often compared with those without detected mutations., Conclusions: Pulmonary hypertensive response to exercise and hypoxia in idiopathic/familial PAH relatives appears as a genetic trait with familial clustering, being correlated to but not caused by a BMPR2 mutation. The suitability of this trait to predict manifest PAH development should be addressed in long-term follow-up studies.
- Published
- 2009
- Full Text
- View/download PDF
46. Fhl-1, a new key protein in pulmonary hypertension.
- Author
-
Kwapiszewska G, Wygrecka M, Marsh LM, Schmitt S, Trösser R, Wilhelm J, Helmus K, Eul B, Zakrzewicz A, Ghofrani HA, Schermuly RT, Bohle RM, Grimminger F, Seeger W, Eickelberg O, Fink L, and Weissmann N
- Subjects
- Animals, Cell Movement, Cell Proliferation, Disease Models, Animal, Humans, Hypertension, Pulmonary pathology, Hypoxia complications, Intracellular Signaling Peptides and Proteins analysis, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins physiology, LIM Domain Proteins, Lung chemistry, Lung metabolism, Mice, Muscle Proteins analysis, Muscle Proteins genetics, Muscle, Smooth, Proteomics methods, Pulmonary Artery, RNA, Small Interfering pharmacology, Up-Regulation, Hypertension, Pulmonary etiology, Muscle Proteins physiology
- Abstract
Background: Pulmonary hypertension (PH) is a severe disease with a poor prognosis. Different forms of PH are characterized by pronounced vascular remodeling, resulting in increased vascular resistance and subsequent right heart failure. The molecular pathways triggering the remodeling process are poorly understood. We hypothesized that underlying key factors can be identified at the onset of the disease. Thus, we screened for alterations to protein expression in lung tissue at the onset of PH in a mouse model of hypoxia-induced PH., Methods and Results: Using 2-dimensional polyacrylamide gel electrophoresis in combination with matrix-assisted laser desorption/ionization time-of-flight analysis, we identified 36 proteins that exhibited significantly altered expression after short-term hypoxic exposure. Among these, Fhl-1, which is known to be involved in muscle development, was one of the most prominently upregulated proteins. Further analysis by immunohistochemistry, Western blot, and laser-assisted microdissection followed by quantitative polymerase chain reaction confirmed the upregulation of Fhl-1, particularly in the pulmonary vasculature. Comparable upregulation was confirmed (1) after full establishment of hypoxia-induced PH, (2) in 2 rat models of PH (monocrotaline-treated and hypoxic rats treated with the vascular endothelial growth factor receptor antagonist SU5416), and (3) in lungs from patients with idiopathic pulmonary arterial hypertension. Furthermore, we demonstrated that regulation of Fhl-1 was hypoxia-inducible transcription factor dependent. Abrogation of Fhl-1 expression in primary human pulmonary artery smooth muscle cells by small-interfering RNA suppressed, whereas Fhl-1 overexpression increased, migration and proliferation. Coimmunoprecipitation experiments identified Talin1 as a new interacting partner of Fhl-1., Conclusions: Protein screening identified Fhl-1 as a novel protein regulated in various forms of PH, including idiopathic pulmonary arterial hypertension.
- Published
- 2008
- Full Text
- View/download PDF
47. The lectin-like domain of tumor necrosis factor-alpha improves alveolar fluid balance in injured isolated rabbit lungs.
- Author
-
Vadász I, Schermuly RT, Ghofrani HA, Rummel S, Wehner S, Mühldorfer I, Schäfer KP, Seeger W, Morty RE, Grimminger F, and Weissmann N
- Subjects
- Animals, In Vitro Techniques, Rabbits, Body Fluids drug effects, Pulmonary Alveoli drug effects, Pulmonary Alveoli physiopathology, Pulmonary Edema etiology, Pulmonary Edema prevention & control, Respiratory Distress Syndrome complications, Tumor Necrosis Factor-alpha therapeutic use
- Abstract
Objective: Identification of mechanisms that preserve optimal alveolar fluid balance during pulmonary edema is of great clinical importance. This study was performed to determine whether the lectin-like domain of tumor necrosis factor-alpha (designated TIP) can improve fluid balance in experimental lung injury by affecting alveolocapillary permeability and/or fluid clearance., Design: Prospective, randomized laboratory investigation., Setting: University-affiliated laboratory., Subjects: Adult male rabbits., Interventions: TIP, a scrambled peptide (scrTIP), dibutyryl cyclic adenosine monophosphate (db-cAMP), or saline was applied to isolated, ventilated, and buffer-perfused rabbit lungs by ultrasonic nebulization, after which hydrostatic edema or endo/exotoxin-induced lung injury was induced and edema formation was assessed. In studies evaluating the resolution of alveolar edema, 2.5 mL of excess fluid was deposited into the alveolar space of isolated lungs by nebulization in the absence or presence of TIP, scrTIP, amiloride, or ouabain or combinations thereof., Measurements and Main Results: Microvascular permeability was largely increased during hydrostatic edema and endo/exotoxin-induced lung injury in saline-treated lungs, or lungs that received scrTIP, as assessed by capillary filtration coefficient (K(f,c)) and fluorescein isothiocyanate-labeled albumin flux across the alveolocapillary barrier. In contrast, TIP- or db-cAMP-treated lungs exhibited significantly lower vascular permeability upon hydrostatic challenge. Similarly, extravascular fluid accumulation, as assessed by fluid retention, wet weight to dry weight ratio, and epithelial lining fluid volume measurements, was largely inhibited by TIP or db-cAMP pretreatment. Furthermore, TIP increased sodium-potassium adenosine triphosphatase (Na,K-ATPase) activity 1.6-fold by promoting Na,K-ATPase exocytosis to the alveolar epithelial cell surface and increased amiloride-sensitive sodium uptake, resulting in a 2.2-fold increase in active Na+ transport, and hence improved clearance of excess fluid from the alveolar space., Conclusions: Aerosolized TIP improved alveolar fluid balance by both reducing vascular permeability and enhancing the absorption of excess alveolar fluid in experimental lung injury. These data may suggest a role for TIP as a potential therapeutic agent in pulmonary edema.
- Published
- 2008
- Full Text
- View/download PDF
48. Fish oil in critical illness.
- Author
-
Mayer K and Seeger W
- Subjects
- Clinical Trials as Topic, Critical Care standards, Enteral Nutrition, Evidence-Based Medicine, Humans, Parenteral Nutrition, Treatment Outcome, Critical Care methods, Critical Illness therapy, Fatty Acids, Omega-3 immunology, Fatty Acids, Omega-3 therapeutic use, Fish Oils chemistry
- Abstract
Purpose of Review: The aim of this review is to discuss recent advances in the role of n-3 lipids derived from fish oil in clinical nutrition in an intensive care setting., Recent Findings: Fish oil supplies n-3 fatty acids which compete with arachidonic acid (n-6) for the conversion to lipid mediators, influence lipid-bound second messenger generation and dependent cellular functions, and are a source for resolvins necessary for the resolution of inflammation. Enteral nutrition with n-3 fatty acids improved ventilation time in patients with acute lung injury and in one study reduced mortality in septic patients. Using a high-dose short-term infusion of fish oil-based lipid emulsion, rapid immunologic changes and effects on the endotoxin-induced stress response may be achieved. Inclusion of n-3 fatty acids in parenteral nutrition improved immunologic parameters and length of stay in surgical patients., Summary: Inclusion of fish oil in nutrition may influence the immune response and clinical outcomes by balancing the negative effects of n-6 fatty acids. Application as a part of enteral immunonutrition in surgical or acute respiratory distress syndrome patients and in lipid emulsions in surgical patients has beneficial effects. In septic patients, data on enteral use are highly controversial. Prospective data from randomized trials, however, are lacking.
- Published
- 2008
- Full Text
- View/download PDF
49. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
- Author
-
Zakrzewicz A, Hecker M, Marsh LM, Kwapiszewska G, Nejman B, Long L, Seeger W, Schermuly RT, Morrell NW, Morty RE, and Eickelberg O
- Subjects
- Adult, Animals, Bone Morphogenetic Protein Receptors, Type II genetics, Down-Regulation genetics, Female, GTP-Binding Proteins genetics, GTP-Binding Proteins metabolism, Humans, Male, Mice, Middle Aged, Muscle, Smooth, Vascular cytology, Mutation, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Protein Binding, Rats, Receptors for Activated C Kinase, Receptors, Cell Surface genetics, Receptors, Cell Surface metabolism, Smad1 Protein metabolism, Two-Hybrid System Techniques, Bone Morphogenetic Protein Receptors, Type II metabolism, Cell Proliferation, GTP-Binding Proteins physiology, Hypertension, Pulmonary pathology, Myocytes, Smooth Muscle pathology, Neoplasm Proteins physiology, Receptors, Cell Surface physiology
- Abstract
Background: Pulmonary arterial hypertension (PAH) is characterized by selective elevation of pulmonary arterial pressure. The pathological hallmark of PAH is the narrowing of pulmonary arterioles secondary to endothelial cell dysfunction and smooth muscle cell proliferation. Heterozygous mutations in BMPR2, encoding the type II bone morphogenetic protein receptor (BMPRII), were identified in PAH, suggesting that alterations to BMPRII function are involved in disease onset and/or progression., Methods and Results: We identified the receptor for activated C-kinase (RACK1) as a novel interaction partner of BMPRII by yeast 2-hybrid analyses using the kinase domain of BMPRII as a bait. Glutathione-S-transferase pull-down and coimmunoprecipitation confirmed the interaction of RACK1 with BMPRII in vitro and in vivo. RACK1-BMPRII interaction was reduced when kinase domain mutations occurring in patients with PAH were introduced to BMPRII. Immunohistochemistry of lung sections from PAH and control patients and immunofluorescence analysis of primary pulmonary arterial smooth muscle cells demonstrated colocalization of BMPRII and RACK1 in vivo. Quantitative reverse-transcription polymerase chain reaction and Western blot analysis showed significant downregulation of RACK1 expression in the rat model of monocrotaline-induced PAH but not in pulmonary arterial smooth muscle cells from PAH patients. Abrogation of RACK1 expression in pulmonary arterial smooth muscle cells led to decreased Smad1 phosphorylation and increased proliferation, whereas overexpression of RACK1 led to increased Smad1 phosphorylation and decreased proliferation., Conclusions: RACK1, a novel interaction partner of BMPRII, constitutes a new negative regulator of pulmonary arterial smooth muscle cell proliferation, suggesting a potential role for RACK1 in the pathogenesis of PAH.
- Published
- 2007
- Full Text
- View/download PDF
50. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
- Author
-
Morty RE, Nejman B, Kwapiszewska G, Hecker M, Zakrzewicz A, Kouri FM, Peters DM, Dumitrascu R, Seeger W, Knaus P, Schermuly RT, and Eickelberg O
- Subjects
- Animals, Apoptosis, Bone Morphogenetic Protein Receptors, Type I metabolism, Bone Morphogenetic Protein Receptors, Type II metabolism, Cell Proliferation, Disease Models, Animal, Disease Progression, Hypertension, Pulmonary chemically induced, Hypertension, Pulmonary pathology, Immunoblotting, Immunohistochemistry, Male, Monocrotaline toxicity, Polymerase Chain Reaction, Pulmonary Artery metabolism, Pulmonary Artery pathology, RNA metabolism, Rats, Rats, Sprague-Dawley, Signal Transduction, Smad4 Protein genetics, Smad4 Protein metabolism, Smad5 Protein genetics, Smad5 Protein metabolism, Smad6 Protein genetics, Smad6 Protein metabolism, Smad8 Protein genetics, Smad8 Protein metabolism, Bone Morphogenetic Protein Receptors, Type I genetics, Bone Morphogenetic Protein Receptors, Type II genetics, Down-Regulation, Hypertension, Pulmonary metabolism, RNA genetics
- Abstract
Background: Mutations in the bmpr2 gene, encoding the type II bone morphogenetic protein (BMP) receptor, have been identified in patients with pulmonary arterial hypertension (PAH), implicating BMP signaling in PAH. The aim of this study was to assess BMP signaling and its physiological effects in a monocrotaline (MCT) model of PAH., Methods and Results: Expression of BMP receptors Ib and II, and Smads 4, 5, 6, and 8, was downregulated in lungs but not kidneys of MCT-treated rats. Smad1 phosphorylation and expression of BMP/Smad target genes id1 and id3 was also reduced, although ERK1/2 and p38(MAPK) phosphorylation remained unaffected. BMP receptor and Smad expression, Smad1 phosphorylation, and induction of the BMP/Smad-responsive element of the id1 promoter were reduced in pulmonary artery smooth muscle cells (PASMCs) from MCT-treated rats. As a consequence of impaired BMP/Smad signaling, PASMCs from MCT-treated rats were resistant to apoptosis induced by BMP-4 and BMP-7, and were also resistant to BMP-4 antagonism of proliferation induced by platelet-derived growth factor., Conclusion: BMP signaling and BMP-regulated physiological phenomena are perturbed in MCT-treated rats, lending solid support to the proposed roles for BMP signaling in the pathogenesis of human PAH.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.